‘There are many moving parts to our novel aerosol technology, deployed by care providers in the most intensive critical care environments, to premature infants as small as 600 grams.  We began working with Charles Albert from the inception of the project, getting needed inputs as to the potential value and key concepts required to gain acceptance and provide safe interfaces with both user and patient at the bedside.  Having worked with Charles Albert in prior projects we knew we could count on CharlesGroups’ experience to conduct the thorough and rigorous human factors evaluations we needed for each level of development. As designers and researchers, they speak our language. They work well with our engineers and developers to design and implement studies that provided effective and efficient feedback that is directly actionable by our development team, helping us to create a superior product. Their studies are tight and on-point, designed and reported in a way they are easy to incorporate into our Agency submittals.”